UC Rat Study Links Low Baseline Corticosterone and High Stress Spikes to PTSD-Like Deficits in Females Only

Researchers at the University of Cincinnati exposed male and female rats first to a mild stressor to measure corticosterone dynamics, then to a prolonged stress protocol modeling PTSD. Behavioral tests weeks later quantified anxiety, fear learning, and extinction. Females showing the low-baseline/high-spike pattern exhibited the poorest outcomes, while male reactivity did not predict deficits. This sex-specific signature aligns with human epidemiology showing women diagnosed with PTSD at roughly twice the rate of men after comparable trauma.

The design isolates glucocorticoid reactivity as a candidate pre-trauma vulnerability marker rather than a post-diagnosis correlate. Prior observational work, including a 2022 meta-analysis in JAMA Psychiatry of 15,000 trauma survivors, documented similar sex differences in HPA-axis tone but lacked prospective biomarker testing. The current preclinical data extend those findings by demonstrating that the same hormone pattern precedes behavioral dysfunction and operates differently across sexes, a distinction often averaged out in mixed-sex human studies.

Translation to patients requires prospective cohorts measuring corticosterone responses before and after trauma, plus neuroimaging to map circuit differences. The authors correctly flag the absence of human validation and note that blocking the post-exposure stress surge remains speculative. A next-step study would need at least 300 trauma-exposed women with serial hormone sampling and 12-month PTSD diagnostic follow-up to test predictive accuracy above 70 percent.

If replicated, the biomarker could stratify early-intervention trials, such as brief glucocorticoid modulation, but current evidence remains limited to rodent models and cannot yet guide clinical decisions.